Anti-dyskinetic effects of cannabinoids in a rat model of Parkinson's disease: role of CB(1) and TRPV1 receptors. [electronic resource]
Producer: 20080117Description: 110-9 p. digitalISSN:- 0014-4886
- Amidohydrolases -- antagonists & inhibitors
- Animals
- Antiparkinson Agents -- adverse effects
- Arachidonic Acids -- metabolism
- Basal Ganglia -- metabolism
- Benzamides -- therapeutic use
- Benzoxazines -- therapeutic use
- Cannabinoids -- agonists
- Capsaicin -- analogs & derivatives
- Carbamates -- therapeutic use
- Drug Therapy, Combination
- Dyskinesia, Drug-Induced -- metabolism
- Endocannabinoids
- Levodopa -- adverse effects
- Male
- Morpholines -- therapeutic use
- Naphthalenes -- therapeutic use
- Oxidopamine
- Parkinson Disease, Secondary -- chemically induced
- Polyunsaturated Alkamides -- metabolism
- Rats
- Rats, Wistar
- Receptor, Cannabinoid, CB1 -- drug effects
- TRPV Cation Channels -- antagonists & inhibitors
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.